Replies to post #573434 on NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

It’s a negotiation, and we’ve all heard how good LP is at negotiations. I would take $75 million at this stage.

The larger the amount to settle the longer it’s in Citadel’s et.al. best interest to drag this out as long as possible. Citadel and the other defendants can easily afford collectively to pay $100 million just to make this go away.

Sure, if NWBO was liquid and not needing to dilute shareholders, then nobody really cares how long this takes from the shareholder perspective. But the reality is that shareholders would greatly benefit from a cash infusion from no dilutive sources.

If CohenMilstein really is holding a strong hand, then this is the right time to leverage it. That’s a more strategic way to think about all of this.

[skitahoe]

If they're truly offering $100 million now it's possible that they'd settle for perhaps $250 right now, I frankly think we could make better use of that today than $1 billion in 4 or 5 years. I agree that I wouldn't settle for $100 million, but substantially better than that would get my attention.

While $250 million represents only about a quarter per share at the time of the major spoofing effort, far less than was lost, it still would be enough to take us through initial approvals and perhaps initiate a trial for DCVax-Direct, If we gain billions in 5 years, I suspect that by that time we'll be earning billions annually, it will be nice, but it won't be needed. I think we could put a quarter billion or more to better work now than billions 5 years from now.

Gary